TrialBiomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals2023

Thymidine kinase activity levels in serum can identify HR+ metastatic breast cancer patients with a low risk of early progression (SWOG S0226).

Mattias Bergqvist et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.